Target intelligence / Profile preview

Dengue Virus Antigen (DENV Antigen)

Target
DENV Antigen
Molecular classification
Viral protein, Structural protein, Nonstructural protein, Glycoprotein
01

Overview

Dengue virus antigens refer to the protein components of the dengue virus (DENV) that are recognized by the host immune system. DENV is a positive-sense, single-stranded RNA virus belonging to the Flaviviridae family and genus Flavivirus. It is primarily transmitted by Aedes mosquitoes and causes dengue fever, which can progress to severe forms such as dengue hemorrhagic fever or dengue shock syndrome. The antigens are classified into structural (Capsid, pre-membrane/membrane, and envelope proteins) and nonstructural (NS1-NS5) proteins. NS1 is a key diagnostic target, while the E protein is the main target for neutralizing antibodies. There are five serotypes of DENV (DENV-1, DENV-2, DENV-3, DENV-4, and DENV-5).

Other names
DENV AntigensDengue virus capsid proteinDengue virus pre-membrane/membrane proteinDengue virus envelope proteinDengue virus nonstructural protein 1Dengue virus NS1 proteinDengue virus E proteinDengue virus C proteinDengue virus prM/M protein
02

Biological functions

Viral replicationImmune evasionVirion assemblyReceptor bindingMembrane fusionGenome packaging
03

Disease associations

Dengue feverDengue hemorrhagic feverDengue shock syndromeInfection
04

Safety considerations

Antibody-dependent enhancement (ADE) with non-neutralizing antibodies
05

Biomarkers

NS1 antigen (diagnostic marker)

Beyond the preview

Go deeper on Dengue Virus Antigen (DENV Antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dengue Virus Antigen (DENV Antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call